Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
19.07
-0.22 (-1.14%)
At close: Dec 18, 2025, 4:00 PM EST
18.99
-0.08 (-0.42%)
After-hours: Dec 18, 2025, 7:12 PM EST
Baxter International Market Cap
Baxter International has a market cap or net worth of $9.8 billion as of December 18, 2025. Its market cap has decreased by -42.05% in one year.
Market Cap
9.80B
Enterprise Value
17.79B
1-Year Change
-42.05%
Ranking
Category
Stock Price
$19.07
Market Cap Chart
Since December 1, 1998, Baxter International's market cap has decreased from $18.88B to $9.80B, a decrease of -48.06%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 9.80B | -34.16% |
| Dec 31, 2024 | 14.89B | -24.09% |
| Dec 29, 2023 | 19.61B | -23.67% |
| Dec 30, 2022 | 25.70B | -40.22% |
| Dec 31, 2021 | 42.98B | 4.86% |
| Dec 31, 2020 | 40.99B | -3.99% |
| Dec 31, 2019 | 42.69B | 21.89% |
| Dec 31, 2018 | 35.03B | -0.55% |
| Dec 29, 2017 | 35.22B | 46.03% |
| Dec 30, 2016 | 24.12B | 15.57% |
| Dec 31, 2015 | 20.87B | -47.46% |
| Dec 31, 2014 | 39.72B | 5.24% |
| Dec 31, 2013 | 37.74B | 3.07% |
| Dec 31, 2012 | 36.62B | 31.26% |
| Dec 30, 2011 | 27.90B | -5.42% |
| Dec 31, 2010 | 29.50B | -16.62% |
| Dec 31, 2009 | 35.38B | 6.44% |
| Dec 31, 2008 | 33.24B | -9.71% |
| Dec 31, 2007 | 36.81B | 21.24% |
| Dec 29, 2006 | 30.36B | 29.31% |
| Dec 30, 2005 | 23.48B | 10.27% |
| Dec 31, 2004 | 21.29B | 14.31% |
| Dec 31, 2003 | 18.63B | 12.13% |
| Dec 31, 2002 | 16.61B | -47.53% |
| Dec 31, 2001 | 31.66B | 21.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |